The IEM Otto Schmitt Distinguished Lecture Series is designed to foster discussion of the grand challenges for engineering in medicine. IEM invites national opinion leaders in research, industry, and government to give one or two talks each academic year.

These public lectures are named in honor of Dr. Otto Schmitt, a longtime University professor of biophysics, bioengineering, and electrical engineering, who made significant contributions to a wide range of fields including submarine detection, electrocardiography, and quality of life measures. 

Anthony Atala announced as the next Otto Schmitt Lecturer

Questions?

Thank you for joining us!

October 9, 2024
11:30 AM - 1:00 PM
Health Sciences Education Center (3-110)
UMN Twin Cities Campus (In-person Only)

"Regenerative Medicine: Current Concepts and Changing Trends"

There is a severe shortage of donor organs and tissues which is worsening yearly due to the aging population. Regenerative medicine and tissue engineering apply the principles of cell transplantation, material sciences, and bioengineering to construct biological substitutes that may restore and maintain normal function in diseased and injured tissues. Stem cells may also offer a potentially limitless source of cells. 3D bioprinting is being utilized for potential tissue engineering therapies, and Body-on-a-Chip technologies are being applied for drug discovery and personalized medicine.  Applications of these new technologies that may offer novel diagnostics and therapies for patients with tissue injury and organ disease will be described. Recent advances that have occurred in regenerative medicine will be reviewed.

Anthony Atala, MD

Professor, Urology
Professor, Wake Forest Institute for Regenerative Medicine
Research Interests: Tissue Engineering, Stem Cells, Regenerative Medicine, Prostatic Neoplasms, Tissue Scaffolds, Reconstructive Surgery

Expand all

Biographical Summary

Anthony Atala, MD

Dr. Atala is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine and the W. Boyce Professor and Chair of the Department of Urology at Wake Forest University. His work focuses on bioprinting and growing human cells, tissues and organs. Sixteen applications of technologies developed in Dr. Atala's laboratory have been used clinically in human patients.

Dr. Atala was elected to the Institute of Medicine (now the National Academy of Medicine), to the National Academy of Inventors as a Charter Fellow, and to the American Institute for Medical and Biological Engineering. Dr. Atala is a recipient of the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently working on a discovery that will significantly affect society; the World Technology Award in Health and Medicine, for achieving significant and lasting progress; the Edison Science/Medical Award; the Fast Company World Changing Ideas Award; the R&D Innovator of the Year Award; the Smithsonian Ingenuity Award, and the Jacobson Innovation Award of the American College of Surgeons for pioneering work in regenerative medicine.

Dr. Atala’s work was listed twice as Time Magazine’s top 10 medical breakthroughs of the year, and as one of 5 discoveries that will change the future of organ transplants. Dr. Atala’s work was ranked by the Project Management Institute as one of the top 10 most impactful biotech projects of the past 50 years.Dr. Atala was named by Scientific American as one of the world’s most influential people in biotechnology, by U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century, by Life Sciences Intellectual Property Review as one of 50 key influencers in the life sciences intellectual property arena, and by Nature Biotechnology as one of the top 10 translational researchers in the world.

Dr. Atala has led or served several national professional and government committees, including the National Institutes of Health working group on Cells and Developmental Biology, the National Institutes of Health Bioengineering Consortium, and the National Cancer Institute’s Advisory Board. He was a Founder of the Tissue Engineering Society, the Regenerative Medicine Society, the Regenerative Medicine Foundation, the Alliance for Regenerative Medicine, the Regenerative Medicine Development Organization, the Regenerative Medicine Manufacturing Society, and the Regenerative Medicine Manufacturing Consortium. He serves as Chair of the Board of Regents of the American College of Surgeons.

Dr. Atala works with several journals and serves in various roles, including Editor-in-Chief of two journals, Stem Cells Translational Medicine and BioPrinting. He is the editor of 26 books, has published more than 800 journal articles and has applied for or received over 300 national and international patents.